Aurora Therapeutics, a startup building personalized gene-editing drugs, has scrapped its and cut staff.
The move comes just seven months after the company launched.
A spokesperson declined to say how many employees were laid off, or whether any of the three-person leadership team would stay.
The company's chief scientific officer left in 2026.